Related Experiment Videos
Ribonuclease activity of human cerebrospinal fluid
Summary
Elevated cerebrospinal fluid ribonuclease activity, particularly in chronic cerebrovascular disease, spinal cord compression, and tumors, can aid diagnosis when protein levels are normal. This enzyme activity likely originates from the bloodstream.
Area of Science:
- Biochemistry
- Neurology
- Clinical Diagnostics
Background:
- Cerebrospinal fluid (CSF) analysis is crucial for diagnosing neurological disorders.
- Ribonuclease (RNAase) activity in CSF has not been extensively characterized.
- Understanding CSF enzyme profiles can offer diagnostic insights.
Purpose of the Study:
- To investigate the ribonuclease activity levels in the cerebrospinal fluid of a patient cohort.
- To determine if elevated CSF RNAase activity correlates with specific neurological conditions.
- To characterize the molecular properties of CSF ribonucleases.
Main Methods:
- Enzyme activity assays were performed on CSF samples from 219 patients.
- Molecular weights of CSF ribonucleases were estimated.
- Immunological methods were used to investigate enzyme origins.
Main Results:
- Normal CSF ribonuclease activity was established at 269 +/- 95 units/ml.
- Consistent elevations (>550 units/ml) were observed in chronic cerebrovascular disease, spinal cord compression, and tumors.
- The major CSF ribonuclease species has a molecular weight of approximately 33,000.
- Increased CSF RNAase activity is not specific to any single disease but aids in diagnosis when CSF protein is normal.
- CSF RNAase activity is not attributed to blood cells and appears to be derived from the bloodstream.
Conclusions:
- Elevated CSF ribonuclease activity serves as a potential biomarker for certain neurological conditions.
- The findings suggest a systemic origin for CSF ribonuclease activity, likely from the blood.
- Further research is needed to definitively exclude a neuronal origin.